Clinical Trials · NCT01484262
Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,344
- Start date
- Nov 2011
- Locations
- 1 site, Germany
- Primary endpoint
- Diabetes-related quality of life assessed by ADDQoL (Audit of Diabetes-Dependent Quality of Life)